Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for…
By R. Pauwels, A. Buist, P. Calverley, C. Jenkins, S. Hurd, Claude Lenfant. Respiratory care, 2001
1,311 citations recorded by the source corpus.
Chronic obstructive pulmonary disease is a major cause of chronic morbidity and mortality throughout the world. COPD is currently the fourth leading cause of death in the world, and further increases in the prevalence and mortality of the disease can be predicted in the coming decades. A unified international effort is required to reverse these trends. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) is a collaborative project of the United States NHLBI and WHO. Its goals are to increase awareness of COPD and decrease morbidity and mortality from this disease. GOLD aims to improve prevention and management of COPD through a concerted worldwide effort of people involved in all facets of health care and health care policy, and to encourage a renewed research interest in this extremely prevalent disease. The GOLD Workshop Report, Global Strategy for the Diagnosis, Management, and Prevention of COPD, presents a COPD management plan with 4 components: (1) assess and monitor disease, (2) reduce risk factors, (3) manage stable COPD, and (4) manage exacerbations. The Workshop Report is based on the best-validated current concepts of COPD pathogenesis and the available evidence on the most appropriate management and prevention strategies. It has been developed by individuals with expertise in COPD research and patient care and extensively reviewed by many experts and scientific societies. Before its release for publication, the Workshop Report was reviewed by the NHLBI and the WHO. This Executive Summary provides key information about COPD; the full Workshop Report provides more details.
Subfields: Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/b52f862b3dfcf5b1679fc6f7dfcb47dd50ea10f4
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Pulmonary and Respiratory Medicine
Citations in the corpus
- The nature of small-airway obstruction in chronic obstructive pulmonary disease. (2004, background): “There are 5 stages of COPD, classified according to objective spirometry measurements, ranging from stage 0 (patient at risk with normal spirometry measures) to stage 4 (patient with FEV1 <30% of predicted values).(2)”
- α-Terpineol, a natural monoterpene: A review of its biological properties (2018, background): “COPD can lead to the restriction of lung function” [48,49].”